-
1
-
-
0023838532
-
1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease
-
1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52: 487-501.
-
(1988)
Cell
, vol.52
, pp. 487-501
-
-
Abraham, C.R.1
Selkoe, D.J.2
Potter, H.3
-
4
-
-
0019965195
-
Further characterization of amyloid-enhancing factor
-
Axelrad MA, Kisilevlky R, Willmer J, Chen SJ, Skinner M (1982): Further characterization of amyloid-enhancing factor. Lab Invest 47:139-146.
-
(1982)
Lab Invest
, vol.47
, pp. 139-146
-
-
Axelrad, M.A.1
Kisilevlky, R.2
Willmer, J.3
Chen, S.J.4
Skinner, M.5
-
5
-
-
0027158642
-
Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease
-
Brachova L, Lue L-F, Schultz J, El Rashidy T, Rogers J (1993): Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease. Mol Brain Res 18: 329-334.
-
(1993)
Mol Brain Res
, vol.18
, pp. 329-334
-
-
Brachova, L.1
Lue, L.-F.2
Schultz, J.3
El Rashidy, T.4
Rogers, J.5
-
6
-
-
0026595567
-
Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs
-
Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992): Assembly and aggregation properties of synthetic Alzheimer's A4/β amyloid peptide analogs. J Biol Chem 267:546-554.
-
(1992)
J Biol Chem
, vol.267
, pp. 546-554
-
-
Burdick, D.1
Soreghan, B.2
Kwon, M.3
Kosmoski, J.4
Knauer, M.5
Henschen, A.6
Yates, J.7
Cotman, C.8
Glabe, C.9
-
7
-
-
0028588694
-
Congo Red protects against toxicity of β-amyloid peptides on rat hippocampal neurones
-
Burgevin MC, Passat M, Daniel N, Doble A (1994): Congo Red protects against toxicity of β-amyloid peptides on rat hippocampal neurones. NeuroReport 5:2429-2432.
-
(1994)
NeuroReport
, vol.5
, pp. 2429-2432
-
-
Burgevin, M.C.1
Passat, M.2
Daniel, N.3
Doble, A.4
-
8
-
-
0028986408
-
Fibrillogenesis in Alzheimer's disease of amyloid ßpeptides and apolipoprotein E
-
Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B (1995): Fibrillogenesis in Alzheimer's disease of amyloid ßpeptides and apolipoprotein E. Biochem J 306:599-604.
-
(1995)
Biochem J
, vol.306
, pp. 599-604
-
-
Castano, E.M.1
Prelli, F.2
Wisniewski, T.3
Golabek, A.4
Kumar, R.A.5
Soto, C.6
Frangione, B.7
-
9
-
-
0023899417
-
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis
-
Coria F, Castano E, Prelli F, Larrondo-Lillo M, Van Duinen S, Shelanski ML, Frangione B (1988): Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 58:454-458.
-
(1988)
Lab Invest
, vol.58
, pp. 454-458
-
-
Coria, F.1
Castano, E.2
Prelli, F.3
Larrondo-Lillo, M.4
Van Duinen, S.5
Shelanski, M.L.6
Frangione, B.7
-
10
-
-
0025951302
-
Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
-
Diedrich JF, Minnigan H, Carp RI, Whitaker JN, Race R, Frey W II, Haase AT (1991): Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J Virol 65: 4759-4768.
-
(1991)
J Virol
, vol.65
, pp. 4759-4768
-
-
Diedrich, J.F.1
Minnigan, H.2
Carp, R.I.3
Whitaker, J.N.4
Race, R.5
Frey II, W.6
Haase, A.T.7
-
11
-
-
0024340461
-
Immunodetection of the amyloid P component in Alzheimer's disease
-
Duong T, Pommier EC, Scheibel AB (1989): Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 78:429-437.
-
(1989)
Acta Neuropathol
, vol.78
, pp. 429-437
-
-
Duong, T.1
Pommier, E.C.2
Scheibel, A.B.3
-
14
-
-
0028872558
-
Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease
-
Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT (1995): Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer disease. Proc Natl Acad Sci USA 92:763-767.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 763-767
-
-
Evans, K.C.1
Berger, E.P.2
Cho, C.-G.3
Weisgraber, K.H.4
Lansbury, P.T.5
-
16
-
-
0027186334
-
The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
-
Ghiso J, Matsubara E, Koudinov A, Choi-Miura NH, Tomita M, Wisniewski T, Frangione B (1993): The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 293:27-30.
-
(1993)
Biochem J
, vol.293
, pp. 27-30
-
-
Ghiso, J.1
Matsubara, E.2
Koudinov, A.3
Choi-Miura, N.H.4
Tomita, M.5
Wisniewski, T.6
Frangione, B.7
-
17
-
-
0019153066
-
Amyloid deposits and amyloidosis: The beta-fibrilloses
-
Glenner GG (1980): Amyloid deposits and amyloidosis: The beta-fibrilloses. N Engl J Med 302:1283-1292.
-
(1980)
N Engl J Med
, vol.302
, pp. 1283-1292
-
-
Glenner, G.G.1
-
18
-
-
0021256895
-
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
-
Glenner GG, Wong CW (1984): Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890.
-
(1984)
Biochem Biophys Res Commun
, vol.120
, pp. 885-890
-
-
Glenner, G.G.1
Wong, C.W.2
-
19
-
-
0027425059
-
Sequestration of amyloid β-peptide
-
Goldgaber D, Schwarzman AI, Bhasin R, Gregori L, Schmechel D, Saunders AM, Roses AD, Strittmatter WJ (1993): Sequestration of amyloid β-peptide. Ann NY Acad Sci 695:139-143.
-
(1993)
Ann NY Acad Sci
, vol.695
, pp. 139-143
-
-
Goldgaber, D.1
Schwarzman, A.I.2
Bhasin, R.3
Gregori, L.4
Schmechel, D.5
Saunders, A.M.6
Roses, A.D.7
Strittmatter, W.J.8
-
20
-
-
0029075189
-
Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide
-
Hamazaki H (1995): Amyloid P component promotes aggregation of Alzheimer's beta-amyloid peptide. Biochem Biophys Res Commun 211:349-353.
-
(1995)
Biochem Biophys Res Commun
, vol.211
, pp. 349-353
-
-
Hamazaki, H.1
-
21
-
-
0028246095
-
Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease
-
Hawkins PN, Rossor MN, Gallimore JR, Miller B, Moore EG, Pepys MB (1994): Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer's disease. Biochem Biophys Res Commun 201: 722-726.
-
(1994)
Biochem Biophys Res Commun
, vol.201
, pp. 722-726
-
-
Hawkins, P.N.1
Rossor, M.N.2
Gallimore, J.R.3
Miller, B.4
Moore, E.G.5
Pepys, M.B.6
-
22
-
-
0028802246
-
Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component
-
Janciauskiene S, Garcia de Frutos P, Carlemalm E, Dahlback B, Eriksson S (1995): Inhibition of Alzheimer β-peptide fibril formation by serum amyloid P component. J Biol Chem 270: 26041-26044.
-
(1995)
J Biol Chem
, vol.270
, pp. 26041-26044
-
-
Janciauskiene, S.1
Garcia De Frutos, P.2
Carlemalm, E.3
Dahlback, B.4
Eriksson, S.5
-
23
-
-
0027258525
-
The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease
-
Jarret JT, Berger EP, Lansbury PT (1993): The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
-
(1993)
Biochemistry
, vol.32
, pp. 4693-4697
-
-
Jarret, J.T.1
Berger, E.P.2
Lansbury, P.T.3
-
24
-
-
0028178458
-
β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q a chain
-
Jiang H, Burdick D, Glabe CG, Cotman CW, Tenner AJ (1994): β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. J Immunol 152:5050-5059.
-
(1994)
J Immunol
, vol.152
, pp. 5050-5059
-
-
Jiang, H.1
Burdick, D.2
Glabe, C.G.3
Cotman, C.W.4
Tenner, A.J.5
-
25
-
-
0025905126
-
Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders
-
Kalaria RN, Galloway PG, Perry G (1991): Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders. Neuropathol Appl Neurobiol 17:189-201.
-
(1991)
Neuropathol Appl Neurobiol
, vol.17
, pp. 189-201
-
-
Kalaria, R.N.1
Galloway, P.G.2
Perry, G.3
-
26
-
-
0027080695
-
Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition
-
Kisilevsky R (1992): Proteoglycans, glycosaminoglycans, amyloid-enhancing factor, and amyloid deposition. J Intern Med 232: 515-516.
-
(1992)
J Intern Med
, vol.232
, pp. 515-516
-
-
Kisilevsky, R.1
-
27
-
-
0028853238
-
Apolipoprotein E (apoE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease
-
Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari T (1995): Apolipoprotein E (apoE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet 95:39-42.
-
(1995)
Hum Genet
, vol.95
, pp. 39-42
-
-
Lehtimaki, T.1
Pirttila, T.2
Mehta, P.D.3
Wisniewski, H.M.4
Frey, H.5
Nikkari, T.6
-
28
-
-
0027502784
-
Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
-
LeVine H (1993): Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Sci 2:404-410.
-
(1993)
Protein Sci
, vol.2
, pp. 404-410
-
-
LeVine, H.1
-
29
-
-
0001733723
-
Thioflavine T interaction with amyloid β-sheet structures Amyloid
-
LeVine H (1995): Thioflavine T interaction with amyloid β-sheet structures Amyloid. Int J Exp Clin Invest 2:1-6.
-
(1995)
Int J Exp Clin Invest
, vol.2
, pp. 1-6
-
-
LeVine, H.1
-
30
-
-
0028007537
-
Binding of serum amyloid P component to heparin in human serum
-
Li XA, Hatanaka K, Guo L, Kitamura Y, Yamamoto A (1994): Binding of serum amyloid P component to heparin in human serum. Biochim Biophys Acta 1201:143-148.
-
(1994)
Biochim Biophys Acta
, vol.1201
, pp. 143-148
-
-
Li, X.A.1
Hatanaka, K.2
Guo, L.3
Kitamura, Y.4
Yamamoto, A.5
-
32
-
-
0028172886
-
β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red
-
Lorenzo A, Yankner BA (1994): β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc Natl Acad Sci USA 91:12243-12247.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 12243-12247
-
-
Lorenzo, A.1
Yankner, B.A.2
-
33
-
-
0028173205
-
1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
-
1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372:92-94.
-
(1994)
Nature
, vol.372
, pp. 92-94
-
-
Ma, J.1
Yee, A.2
Brewer, H.B.3
Das, S.4
Potter, H.5
-
34
-
-
0027327488
-
Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide
-
Mantyh PW, Ghilardi JR, Rogers S, DeMaster E, Allen CJ, Stimson ER, Maggio JE (1993): Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of β-amyloid peptide. J Neurochem 61:1171-1174.
-
(1993)
J Neurochem
, vol.61
, pp. 1171-1174
-
-
Mantyh, P.W.1
Ghilardi, J.R.2
Rogers, S.3
DeMaster, E.4
Allen, C.J.5
Stimson, E.R.6
Maggio, J.E.7
-
35
-
-
0026493598
-
Analysis for cerebrospinal fluid proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis
-
Mashige F, Shimizu T, Iijima S, Ohkubo A (1992): Analysis for cerebrospinal fluid proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Clin Chem 38:2008-2012.
-
(1992)
Clin Chem
, vol.38
, pp. 2008-2012
-
-
Mashige, F.1
Shimizu, T.2
Iijima, S.3
Ohkubo, A.4
-
36
-
-
0012510759
-
Amyloid plaque core protein in Alzheimer's disease and Down's syndrome
-
Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985): Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc Natl Acad Sci USA 82:4245-4249.
-
(1985)
Proc Natl Acad Sci USA
, vol.82
, pp. 4245-4249
-
-
Masters, C.L.1
Simms, G.2
Weinman, N.A.3
Multhaup, G.4
McDonald, B.L.5
Beyreuther, K.6
-
37
-
-
0028921915
-
Characterization of apolipoprotein J-Alzheimer's Aβ interaction
-
Matsubara E, Frangione B, Ghiso J (1995): Characterization of apolipoprotein J-Alzheimer's Aβ interaction. J Biol Chem 270: 7563-7567.
-
(1995)
J Biol Chem
, vol.270
, pp. 7563-7567
-
-
Matsubara, E.1
Frangione, B.2
Ghiso, J.3
-
38
-
-
0027297138
-
Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF
-
Mattson MP, Tomaselli KJ, Rydel RE (1993): Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res 621:35-49.
-
(1993)
Brain Res
, vol.621
, pp. 35-49
-
-
Mattson, M.P.1
Tomaselli, K.J.2
Rydel, R.E.3
-
40
-
-
0024509805
-
Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T
-
Naiki H, Higuchi K, Hosokawa M, Takeda T (1989): Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavine T. Anal Biochem 177:244-249.
-
(1989)
Anal Biochem
, vol.177
, pp. 244-249
-
-
Naiki, H.1
Higuchi, K.2
Hosokawa, M.3
Takeda, T.4
-
41
-
-
0025826915
-
Kinetic analysis of amyloid fibril polymerization in vitro
-
Naiki H, Higuchi K, Nakakuki K, Takeda T (1991): Kinetic analysis of amyloid fibril polymerization in vitro. Lab Invest 65:104-110.
-
(1991)
Lab Invest
, vol.65
, pp. 104-110
-
-
Naiki, H.1
Higuchi, K.2
Nakakuki, K.3
Takeda, T.4
-
42
-
-
0027994773
-
Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease
-
Nakamura T, Shoji M, Harigaya T, Watanabe M, Hosoda K, Cheung TT, Shaffer LM, Golde TE, Younkin LH, Younkin SG, Hirai S (1994): Amyloid beta protein levels in cerebrospinal fluid are elevated in early-onset Alzheimer's disease. Ann Neurol 36: 903-911.
-
(1994)
Ann Neurol
, vol.36
, pp. 903-911
-
-
Nakamura, T.1
Shoji, M.2
Harigaya, T.3
Watanabe, M.4
Hosoda, K.5
Cheung, T.T.6
Shaffer, L.M.7
Golde, T.E.8
Younkin, L.H.9
Younkin, S.G.10
Hirai, S.11
-
43
-
-
0027970527
-
Purification and characterization of brain clusterin
-
Oda T, Pasinetti GM, Osterburg HH, Anderson C, Johnson SA, Finch CE (1994): Purification and characterization of brain clusterin. Biochem Biophys Res Commun 204:1131-1136.
-
(1994)
Biochem Biophys Res Commun
, vol.204
, pp. 1131-1136
-
-
Oda, T.1
Pasinetti, G.M.2
Osterburg, H.H.3
Anderson, C.4
Johnson, S.A.5
Finch, C.E.6
-
44
-
-
0018641285
-
Binding of serum amyloid P-component (SAP) by amyloid fibrils
-
Pepys MB, Dyck RF, DeBeer FC, Skinner M, Cohen AS (1979): Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin Exp Immunol 38:284-293.
-
(1979)
Clin Exp Immunol
, vol.38
, pp. 284-293
-
-
Pepys, M.B.1
Dyck, R.F.2
DeBeer, F.C.3
Skinner, M.4
Cohen, A.S.5
-
45
-
-
0025992417
-
In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity
-
Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991): In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314.
-
(1991)
Brain Res
, vol.563
, pp. 311-314
-
-
Pike, C.J.1
Walencewicz, A.J.2
Glabe, C.G.3
Cotman, C.W.4
-
46
-
-
0027447286
-
Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
-
Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993): Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13:1676-1687.
-
(1993)
J Neurosci
, vol.13
, pp. 1676-1687
-
-
Pike, C.J.1
Burdick, D.2
Walencewicz, A.J.3
Glabe, C.G.4
Cotman, C.W.5
-
47
-
-
0028981219
-
Structure-activity analyses of β-amyloid peptides: Contributions of the β25-35 region to aggregation and neurotoxicity
-
Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW (1995): Structure-activity analyses of β-amyloid peptides: Contributions of the β25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265.
-
(1995)
J Neurochem
, vol.64
, pp. 253-265
-
-
Pike, C.J.1
Walencewicz-Wasserman, A.J.2
Kosmoski, J.3
Cribbs, D.H.4
Glabe, C.G.5
Cotman, C.W.6
-
48
-
-
10144244720
-
Effect of apolipoprotein E4 allele on soluble β-amyloid protein concentrations in cerebrospinal fluid from patients with Alzheimer's disease and controls
-
Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds): New York: John Wiley & Sons
-
Pirttila T, Mehta PD, Lehtimaki T, Kim KS, Sersen EA, Frey H, Nikkari T, Wisniewski HM (1995): Effect of apolipoprotein E4 allele on soluble β-amyloid protein concentrations in cerebrospinal fluid from patients with Alzheimer's disease and controls. In Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds): "Research Advances in Alzheimer's Disease and Related Disorders." New York: John Wiley & Sons, pp 121-128.
-
(1995)
Research Advances in Alzheimer's Disease and Related Disorders
, pp. 121-128
-
-
Pirttila, T.1
Mehta, P.D.2
Lehtimaki, T.3
Kim, K.S.4
Sersen, E.A.5
Frey, H.6
Nikkari, T.7
Wisniewski, H.M.8
-
49
-
-
0023280054
-
Lipoproteins and their receptors in the central nervous system
-
Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH (1987): Lipoproteins and their receptors in the central nervous system. J Biol Chem 262:14352-14360.
-
(1987)
J Biol Chem
, vol.262
, pp. 14352-14360
-
-
Pitas, R.E.1
Boyles, J.K.2
Lee, S.H.3
Hui, D.4
Weisgraber, K.H.5
-
50
-
-
0023279767
-
A special type of senile plaque, possibly an initial stage
-
Probst A, Brunnschweiler H, Lautenschlager C, Ulrich J (1987): A special type of senile plaque, possibly an initial stage. Acta Neuropathol 74:133-141.
-
(1987)
Acta Neuropathol
, vol.74
, pp. 133-141
-
-
Probst, A.1
Brunnschweiler, H.2
Lautenschlager, C.3
Ulrich, J.4
-
52
-
-
0027374047
-
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
-
Rebeck GW, Reiter JS, Strickland DK, Hyman BT (1993): Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11:575-580.
-
(1993)
Neuron
, vol.11
, pp. 575-580
-
-
Rebeck, G.W.1
Reiter, J.S.2
Strickland, D.K.3
Hyman, B.T.4
-
53
-
-
0026447529
-
Complement activation by β-amyloid in Alzheimer's disease
-
Rogers J, Cooper NR, Webster S, Schultz J, McGeer PL, Styren SD, Civin WH, Brachova L, Bradt B, Ward P, Lieberburg I (1992): Complement activation by β-amyloid in Alzheimer's disease. Proc Natl Acad Sci USA 89:10016-10020.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 10016-10020
-
-
Rogers, J.1
Cooper, N.R.2
Webster, S.3
Schultz, J.4
McGeer, P.L.5
Styren, S.D.6
Civin, W.H.7
Brachova, L.8
Bradt, B.9
Ward, P.10
Lieberburg, I.11
-
54
-
-
0022550027
-
Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein
-
Roher A, Wolfe D, Palutke M, KuKuruga D (1986): Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83: 2622-2666.
-
(1986)
Proc Natl Acad Sci USA
, vol.83
, pp. 2622-2666
-
-
Roher, A.1
Wolfe, D.2
Palutke, M.3
Kukuruga, D.4
-
55
-
-
0028026587
-
Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils
-
Sanan DA, Weisgraber KH, Russell SJ, Mahley RW, Huang D, Saunders A, Schmechel D, Wisniewski T, Frangione B, Roses AD, Strittmatter WJ (1994): Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 94:860-869.
-
(1994)
J Clin Invest
, vol.94
, pp. 860-869
-
-
Sanan, D.A.1
Weisgraber, K.H.2
Russell, S.J.3
Mahley, R.W.4
Huang, D.5
Saunders, A.6
Schmechel, D.7
Wisniewski, T.8
Frangione, B.9
Roses, A.D.10
Strittmatter, W.J.11
-
56
-
-
0027365822
-
Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
-
Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses D (1993): Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:9649-9653.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 9649-9653
-
-
Schmechel, D.E.1
Saunders, A.M.2
Strittmatter, W.J.3
Crain, B.J.4
Hulette, C.M.5
Joo, S.H.6
Pericak-Vance, M.A.7
Goldgaber, D.8
Roses, D.9
-
57
-
-
0027999030
-
Transthyretin sequesters amyloid beta protein and prevents amyloid formation
-
Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, Zagorlki MG, Talafous J, Eisenberg M, Saunders AM, Roses AD, Goldgaber D (1994): Transthyretin sequesters amyloid beta protein and prevents amyloid formation. Proc Natl Acad Sci USA 91:8368-8372.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, pp. 8368-8372
-
-
Schwarzman, A.L.1
Gregori, L.2
Vitek, M.P.3
Lyubski, S.4
Strittmatter, W.J.5
Enghilde, J.J.6
Bhasin, R.7
Silverman, J.8
Weisgraber, K.H.9
Coyle, P.K.10
Zagorlki, M.G.11
Talafous, J.12
Eisenberg, M.13
Saunders, A.M.14
Roses, A.D.15
Goldgaber, D.16
-
58
-
-
0026646605
-
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
-
Seubert P, Vigo-Pelfry C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C, McCormack R, Wolfert R, Selkoe D, Lieberburg I, Schenk D (1992): Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327.
-
(1992)
Nature
, vol.359
, pp. 325-327
-
-
Seubert, P.1
Vigo-Pelfry, C.2
Esch, F.3
Lee, M.4
Dovey, H.5
Davis, D.6
Sinha, S.7
Schlossmacher, M.8
Whaley, J.9
Swindlehurst, C.10
McCormack, R.11
Wolfert, R.12
Selkoe, D.13
Lieberburg, I.14
Schenk, D.15
-
59
-
-
0028265912
-
Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro
-
Simmons LK, May PC, Tomaselli KJ, Rydel RE, Fuson KS, Brigham EF, Wright S, Lieberburg I, Becker GW, Brems DN, Li WY (1994): Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro. Mol Pharmacol 45:373-379.
-
(1994)
Mol Pharmacol
, vol.45
, pp. 373-379
-
-
Simmons, L.K.1
May, P.C.2
Tomaselli, K.J.3
Rydel, R.E.4
Fuson, K.S.5
Brigham, E.F.6
Wright, S.7
Lieberburg, I.8
Becker, G.W.9
Brems, D.N.10
Li, W.Y.11
-
60
-
-
0026771089
-
Amyloidosis
-
Sipe JD (1992): Amyloidosis. Annu Rev Biochem 61:947-975.
-
(1992)
Annu Rev Biochem
, vol.61
, pp. 947-975
-
-
Sipe, J.D.1
-
61
-
-
0028169558
-
Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state
-
Smyth MD, Cribbs DH, Tenner AJ, Schankle WR, Dick M, Kesslak JP, Cotman CW (1994): Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state. Neurobiol Aging 15:609-614.
-
(1994)
Neurobiol Aging
, vol.15
, pp. 609-614
-
-
Smyth, M.D.1
Cribbs, D.H.2
Tenner, A.J.3
Schankle, W.R.4
Dick, M.5
Kesslak, J.P.6
Cotman, C.W.7
-
62
-
-
0028168336
-
Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths
-
Snyder SW, Ladror US, Wade WS, Wang GT, Barrett LW, Matayoshi ED, Huffaker HJ, Krafft GA, Holzman TF (1994a): Amyloid-β aggregation: Selective inhibition of aggregation in mixtures of amyloid with different chain lengths. Biophys J 67: 1216-1228.
-
(1994)
Biophys J
, vol.67
, pp. 1216-1228
-
-
Snyder, S.W.1
Ladror, U.S.2
Wade, W.S.3
Wang, G.T.4
Barrett, L.W.5
Matayoshi, E.D.6
Huffaker, H.J.7
Krafft, G.A.8
Holzman, T.F.9
-
63
-
-
0027966134
-
Complement C1q does not bind monomeric β-amyloid
-
Snyder SW, Wang GT, Barrett L, Ladror US, Casuto D, Lee CM, Krafft GA, Holzman RB, Holzman TF (1994b): Complement C1q does not bind monomeric β-amyloid. Exp Neurol 128: 136-142.
-
(1994)
Exp Neurol
, vol.128
, pp. 136-142
-
-
Snyder, S.W.1
Wang, G.T.2
Barrett, L.3
Ladror, U.S.4
Casuto, D.5
Lee, C.M.6
Krafft, G.A.7
Holzman, R.B.8
Holzman, T.F.9
-
64
-
-
0029119868
-
Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids
-
Soto C, Castano EM, Prelli F, Kumar RA, Baumann M (1995): Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, Gelsolin and AA amyloids. FEBS Lett 371:110-114.
-
(1995)
FEBS Lett
, vol.371
, pp. 110-114
-
-
Soto, C.1
Castano, E.M.2
Prelli, F.3
Kumar, R.A.4
Baumann, M.5
-
65
-
-
12044254746
-
Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease
-
Strittmatter WJ, Weisgraber KH, Huang DY, Dong L-M, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD (1993): Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 8098-8102
-
-
Strittmatter, W.J.1
Weisgraber, K.H.2
Huang, D.Y.3
Dong, L.-M.4
Salvesen, G.S.5
Pericak-Vance, M.6
Schmechel, D.7
Saunders, A.M.8
Goldgaber, D.9
Roses, A.D.10
-
66
-
-
0027053903
-
Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP)
-
Swanson SJ, Christner RB, Mortensen RF (1992): Human serum amyloid P-component (SAP) selectively binds to immobilized or bound forms of C-reactive protein (CRP). Biochim Biophys Acta 1160:309-316.
-
(1992)
Biochim Biophys Acta
, vol.1160
, pp. 309-316
-
-
Swanson, S.J.1
Christner, R.B.2
Mortensen, R.F.3
-
67
-
-
0023798449
-
Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and non-demented individuals
-
Tagliavini F, Giaccone G, Frangione B, Bugiani O (1988): Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and non-demented individuals. Neurosci Lett 93:191-196.
-
(1988)
Neurosci Lett
, vol.93
, pp. 191-196
-
-
Tagliavini, F.1
Giaccone, G.2
Frangione, B.3
Bugiani, O.4
-
69
-
-
0028331604
-
Amyloid beta protein-induced neuronal cell death: Neurotoxic properties of aggregated amyloid beta protein
-
Ueda K, Fukui Y, Kageyama H (1994): Amyloid beta protein-induced neuronal cell death: Neurotoxic properties of aggregated amyloid beta protein. Brain Res 639:240-244.
-
(1994)
Brain Res
, vol.639
, pp. 240-244
-
-
Ueda, K.1
Fukui, Y.2
Kageyama, H.3
-
70
-
-
0028135459
-
Enhanced aggregation and β structure of amyloid β peptide after co-incubation with C1q
-
Webster S, O'Barr S, Rogers J (1994): Enhanced aggregation and β structure of amyloid β peptide after co-incubation with C1q. J Neurosci Res 39:448-456.
-
(1994)
J Neurosci Res
, vol.39
, pp. 448-456
-
-
Webster, S.1
O'Barr, S.2
Rogers, J.3
-
71
-
-
0029417189
-
Multivalent binding of complement protein C1q to the amyloid β-peptide promotes the nucleation phase of Aβ aggregation
-
Webster S, Glabe C, Rogers J (1995): Multivalent binding of complement protein C1q to the amyloid β-peptide promotes the nucleation phase of Aβ aggregation. Biochem Biophys Res Commun 217:869-875.
-
(1995)
Biochem Biophys Res Commun
, vol.217
, pp. 869-875
-
-
Webster, S.1
Glabe, C.2
Rogers, J.3
-
72
-
-
0028303072
-
Apolipoprotein E: Structure-function relationships
-
Weisgraber KH (1994): Apolipoprotein E: Structure-function relationships. Adv Prot Chem 45:249-301.
-
(1994)
Adv Prot Chem
, vol.45
, pp. 249-301
-
-
Weisgraber, K.H.1
-
73
-
-
0002898753
-
Reexamination of the pathogenesis of the senile plaques
-
Wisniewski HM, Terry RD (1973): Reexamination of the pathogenesis of the senile plaques. Prog Neuropathol 11:1-26.
-
(1973)
Prog Neuropathol
, vol.11
, pp. 1-26
-
-
Wisniewski, H.M.1
Terry, R.D.2
-
74
-
-
0027444955
-
Cerebrospinal fluid inhibits Alzheimer β-amyloid fibril formation in vitro
-
Wisniewski T, Castano E, Ghiso J, Frangione B (1993a): Cerebrospinal fluid inhibits Alzheimer β-amyloid fibril formation in vitro. Ann Neurol 34:631-633.
-
(1993)
Ann Neurol
, vol.34
, pp. 631-633
-
-
Wisniewski, T.1
Castano, E.2
Ghiso, J.3
Frangione, B.4
-
75
-
-
0027255422
-
Apolipoprotein E: Binding to soluble Alzheimer beta-amyloid
-
Wisniewski T, Golabek A, Matsubara E, Ghiso J, Frangione B (1993b): Apolipoprotein E: Binding to soluble Alzheimer beta-amyloid. Biochem Biophys Res Commun 192:359-365.
-
(1993)
Biochem Biophys Res Commun
, vol.192
, pp. 359-365
-
-
Wisniewski, T.1
Golabek, A.2
Matsubara, E.3
Ghiso, J.4
Frangione, B.5
-
76
-
-
0027970307
-
Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro
-
Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B (1994): Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030-1035.
-
(1994)
Am J Pathol
, vol.145
, pp. 1030-1035
-
-
Wisniewski, T.1
Castano, E.M.2
Golabek, A.3
Vogel, T.4
Frangione, B.5
-
77
-
-
0029996091
-
Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ
-
Wood SJ, Maleeff B, Hart T, Wetzel R (1996): Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ. J Mol Biol 256: 870-877.
-
(1996)
J Mol Biol
, vol.256
, pp. 870-877
-
-
Wood, S.J.1
Maleeff, B.2
Hart, T.3
Wetzel, R.4
-
78
-
-
0024237246
-
Diffuse type of senile plaques in the brains of Alzheimer-type dementia
-
Yamaguchi H, Hirai S, Morimatsu M, Shoji M, Harigaya Y (1988): Diffuse type of senile plaques in the brains of Alzheimer-type dementia. Acta Neuropathol 77:113-119.
-
(1988)
Acta Neuropathol
, vol.77
, pp. 113-119
-
-
Yamaguchi, H.1
Hirai, S.2
Morimatsu, M.3
Shoji, M.4
Harigaya, Y.5
-
79
-
-
0028610508
-
Brain uptake of circulating apolipoproteins J and e complexed to Alzheimer's amyloid β
-
Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J (1994): Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid β. Biochem Biophys Res Commun 205:1431-1437.
-
(1994)
Biochem Biophys Res Commun
, vol.205
, pp. 1431-1437
-
-
Zlokovic, B.V.1
Martel, C.L.2
Mackic, J.B.3
Matsubara, E.4
Wisniewski, T.5
McComb, J.G.6
Frangione, B.7
Ghiso, J.8
|